The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd & Others

Dr. Sachin D. Patel Address: 67, Chhaya, Swastik Society, JVPD Scheme, N. S. Road No. 5, Vile Parle (West), Mumbai – 400056, Maharashtra. September 1, 2026 Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai- 400001 Bandra (East), Mumbai- 400051 Scrip Code – 506879 Symbol: GUJTHEM corp.relations@bseindia.com takeover@nse.co.in Gujarat Themis Biosyn Limited Block No. 69-c, GIDC Industrial Estate, Vapi – 396195, Gujarat. cfoassist@themismedicare.com Dear Sir / Madam Subject: - Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 This is to inform you that pursuant to Regulation 29(2) of SEBI (SAST) Regulation, 2011, (Takeover Regulations), we hereby submit the disclosure relating to the change in shareholding of the following Promoters and Promoter Group of the Company: The Promoters and Promoters Group of the Company have not acquired any share / voting right in the Company. This reporting is due to considering passive reduction in percentage of shareholding of the Promoters and Promoters Group, due allotment of 2,11,86,440 equity shares to non-promoters (qualified institutional buyers) on 28.08.2026 under QIP issue. Thanking you Dr. Sachin Patel (on behalf of himself and other Promoters / Promoters Group) Encl.: As above Dr. Sachin D. Patel Address: 67, Chhaya, Swastik Society, JVPD Scheme, N. S. Road No. 5, Vile Parle (West), Mumbai – 400056, Maharashtra. Disclosures under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 1 Name of the Target Company (TC) Gujarat Themis Biosyn Limited 2 Name(s) of the acquirer and Persons Pharmaceutical Business Group India Ltd, Acting in Concert (PAC) with the acquirer Themis Medicare Limited, Dinesh Shantilal Patel, Jayshree D Patel, Reena S Patel, Sachin Dinesh Patel, Dinesh Shantilal Patel, Anay Rupen Choksi, Nysha Rupen Choksi and Dinesh S Patel (Vividhmargi Trust) (Promoter and Promoters Gorup) 3 Whether the acquirer belongs to Promoter/ Refer Note. Promoter group. 4 Name(s) of the Stock Exchange(s) where National Stock of India Limited and BSE the shares of TC are Listed. Limited Details of the acquisition / disposal as Number % wrt total % wrt total follows share/voting diluted capital share/voting wherever capital of applicable(*) the TC (**) 5 Before the acquisition under 7,72,18,083 59.33 59.33 consideration, holding of acquirer along with PACs of: a) Shares carrying voting rights b) Shares in the nature of encumbrance $ $ $ (pledge/ lien/ non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by -- -- -- shares d) Warrants/convertible securities/any other -- -- -- instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 7,72,18,083 59.33 59.33 6 Details of acquisition No acquisition. This reporting is due to passive reduction in shareholding of Promoters and Promoter Group (Refer Note) a) Shares carrying voting rights Refer Note Refer Note Refer Note b) VRs acquired otherwise than by equity --- ---- --- shares c) Warrants/convertible securities/any --- ---- --- other instrument that entitles the acquirer to receive shares carrying Dr. Sachin D. Patel Address: 67, Chhaya, Swastik Society, JVPD Scheme, N. S. Road No. 5, Vile Parle (West), Mumbai – 400056, Maharashtra. voting rights in the TC (specify holding in each category) acquired / sold. d) Shares encumbrance / invoked / --- ---- --- released by the acquirer e) Total (a+b+c+d) 7 After the acquisition / sale, holding of: Refer Note Refer Note Refer Note a) Shares carrying voting rights 7,72,18,083 59.33 59.33 b) Shares encumbered with the acquirer $ $ $ c) VRs otherwise than by shares -- -- -- d) Warrants/convertible securities/any -- --- -- other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition. e) Total (a+b+c+d) 7,72,18,083 59.33 59.33 8 Mode of acquisition / sale (e.g. open Note Applicable / Refer Note market / off-market / public issue / rights issue / preferential allotment / inter-se transfer etc) 9 Date of acquisition / sale of shares / VR or Note Applicable / Refer Note date of receipt of intimation of allotment of shares, whichever is applicable. 10 Equity share capital / total voting capital of Note Applicable / Refer Note the TC before the said acquisition / sale. 11 Equity share capital/ total voting capital of Note Applicable / Refer Note the TC after the said acquisition / sale. 12 Total diluted share/voting capital of the Note Applicable / Refer Note TC after the said acquisition. 13 Date of acquisition of/ date of receipt of Note Applicable / Refer Note intimation of allotment of shares / VR/ warrants/convertible securities/any other instrument that entitles the acquirer to receive shares in the TC. 14 Equity share capital / total voting capital of 10,89,65,265 equity shares of face value of the TC before the said acquisition Rs. 1 each, fully paid-up 15 Equity share capital/ total voting capital of 13,01,51,705 equity shares of face value of the TC after the said acquisition Rs. 1 each, fully paid-up 16 Total diluted share/voting capital of the 13,01,51,705 equity shares of face value of TC after the said acquisition Rs. 1 each, fully paid-up (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Regulation 31(b) of SEBI (LODR) Regulations, 2015. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Dr. Sachin D. Patel Address: 67, Chhaya, Swastik Society, JVPD Scheme, N. S. Road No. 5, Vile Parle (West), Mumbai – 400056, Maharashtra. Note: Promoters and Promoter Gorup of the Company have not acquired any share / voting right in the Company. This reporting is due to considering passive reduction in percentage of shareholding of Pharmaceutical Business Group India Ltd, Themis Medicare Limited, Dinesh Shantilal Patel, Jayshree D Patel, Reena S Patel, Sachin Dinesh Patel, Dinesh Shantilal Patel, Anay Rupen Choksi, Nysha Rupen Choksi and Dinesh S Patel (Vividhmargi Trust), due to allotment of 2,11,86,440 equity shares to non-promoters (public category / QIBs) on dated 28.08.2026 by way Qualified Institutions Placement. $ There is an indirect incumbrance on 5,12,40,000 shares (39.37% of total) held by Pharmaceutical Business Group India Ltd, a promoter group entity. Separate disclosure has already been made at relevant time. Dr. Sachin Patel (on behalf of himself and other promoters’ / promoters group) Place: Mumbai Date: 01.09.2026